156 related articles for article (PubMed ID: 12270329)
1. Contribution of renal scintigraphy to management of patients with acute renal allograft dysfunction.
Aktas A; Moray G; Karakayali H; Bilgin N
Transplant Proc; 2002 Sep; 34(6):2099-101. PubMed ID: 12270329
[No Abstract] [Full Text] [Related]
2. Comparison of Tc-99m DTPA and Tc-99m MAG3 perfusion time-activity curves in patients with renal allograft dysfunction.
Aktaş A; Aras M; Colak T; Gençoğlu A; Karakayali H
Transplant Proc; 2006 Mar; 38(2):449-53. PubMed ID: 16549144
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal.
Cronin DC; Bruce DS; Newell KA; Josephson MA; Millis JM; Piper JB; Ruebe M; Kirby M; Thistlethwaite JR; Woodle ES
Transplant Proc; 1997; 29(1-2):307. PubMed ID: 9123010
[No Abstract] [Full Text] [Related]
4. Serial radionuclide imaging in acute renal allograft dysfunction.
Aktas A; Karakayali H; Bilgin N; Akkoc H; Moray G; Emiroglu R
Transplant Proc; 2002 Sep; 34(6):2102-5. PubMed ID: 12270330
[No Abstract] [Full Text] [Related]
5. Preliminary results of [99mTc]OKT3 scintigraphy to evaluate acute rejection in renal transplants.
Martins FP; Souza SA; Gonçalves RT; Fonseca LM; Gutfilen B
Transplant Proc; 2004 Nov; 36(9):2664-7. PubMed ID: 15621118
[TBL] [Abstract][Full Text] [Related]
6. OKT3 versus methylprednisolone for primary treatment of rejection: a retrospective evaluation.
Meijer RT; Keur I; Surachno S; ten Berge IJ; Schellekens PT
Transplant Proc; 2001 May; 33(3):2196-7. PubMed ID: 11377501
[No Abstract] [Full Text] [Related]
7. FK506 rescue therapy for acute renal allograft rejection.
Goh BL; Morad Z; Cheah PL; Chua CT; Tan SY
Transplant Proc; 1998 Nov; 30(7):3592-3. PubMed ID: 9838574
[No Abstract] [Full Text] [Related]
8. Classification of Tc-99m DTPA perfusion time-activity curves in renal transplant recipients.
Aktas A; Yalçin H; Koyuncu A; Haberal M
Transplant Proc; 2003 Nov; 35(7):2625-7. PubMed ID: 14612045
[No Abstract] [Full Text] [Related]
9. A prospective study of technetium-99m-diethylenetriamine pentaacetic acid renal allograft scintigraphy in the diagnostic evaluation of graft dysfunction.
Bellomo R; Farmer M; Wong C; Boyce N
Transplantation; 1993 Dec; 56(6):1585-8. PubMed ID: 8279048
[No Abstract] [Full Text] [Related]
10. The value of quantitative Tc-99m diethylenetriamine pentaacetic acid scintigraphy for assessing pediatric renal transplant recipients.
Gencoglu EA; Moray G; Karakayali H; Emiroglu R; Haberal M
Transplant Proc; 2003 Nov; 35(7):2630-3. PubMed ID: 14612047
[No Abstract] [Full Text] [Related]
11. Impact of OKT3 treatment for steroid resistant rejection of renal allografts: the long-term outcome at a single center.
Inui M; Tanabe K; Ishikawa N; Tokumoto T; Harano M; Otsubo S; Suzuki K; Goya N; Yagisawa T; Nakazawa H; Fuchinoue S; Toma H
Transplant Proc; 1999 Nov; 31(7):2870-1. PubMed ID: 10578320
[No Abstract] [Full Text] [Related]
12. A comparative analysis of methyl prednisone pulse versus orthoclone therapy in the management of acute cellular rejection.
Nampoory MR; Johny KV; Costandi JN; al-Muzairai IM; Gupta RK; Nair MP; Samhan M; al-Mousawi M
Transplant Proc; 1997 Nov; 29(7):2967-70. PubMed ID: 9365632
[No Abstract] [Full Text] [Related]
13. Indicators of acute rejection on Tc-99m DTPA renal scintigraphy.
Aktaş A; Aras M; Colak T; Gençoğlu A; Moray G
Transplant Proc; 2006 Mar; 38(2):443-8. PubMed ID: 16549143
[TBL] [Abstract][Full Text] [Related]
14. Successful therapy of chronic renal allograft failure by enhanced immunosuppression.
Kliem V; Tiroke T; Ehlerding G; Eberhard O; Behrend M; Frei U; Koch KM; Pichlmayr R; Brunkhorst R
Transplant Proc; 1998 Jun; 30(4):1207-9. PubMed ID: 9636490
[No Abstract] [Full Text] [Related]
15. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
[No Abstract] [Full Text] [Related]
16. Predicting factors for long-term results of OKT3 therapy in steroid-resistant acute rejection following cadaveric renal transplantation.
Rostaing L; Chabannier MH; Modesto A; Rouzaud A; Cisterne JM; Tkaczuk J; Durand D
Transplant Proc; 1998 Jun; 30(4):1170-2. PubMed ID: 9636473
[No Abstract] [Full Text] [Related]
17. Graft outcome in patients with biopsy-proven chronic renal allograft rejection.
Peddi VR; Schroeder TJ; Weiskittel P; First MR
Transplant Proc; 1999; 31(1-2):1308-9. PubMed ID: 10083584
[No Abstract] [Full Text] [Related]
18. Effectiveness of short-term OKT3 therapy in the treatment of steroid-resistant renal allograft rejection.
Carvalho MF; Adoni T; Saggioro FP; Soares V
Transplant Proc; 1998 Sep; 30(6):2876-7. PubMed ID: 9745607
[No Abstract] [Full Text] [Related]
19. Acute vascular rejection in renal transplantation.
Salmela K; von Willebrand E; Kyllönen L; Eklund B; Höckerstedt K; Isoniemi H; Krogerus L; Taskinen E; Ahonen J
Transplant Proc; 1992 Feb; 24(1):360-1. PubMed ID: 1539318
[No Abstract] [Full Text] [Related]
20. [Follow-up after kidney transplantation. Sequential functional scintigraphy with technetium-99m-DTPA or technetium-99m-MAG3].
Kramer W; Baum RP; Scheuermann E; Hör G; Jonas D
Urologe A; 1993 Mar; 32(2):115-20. PubMed ID: 8475609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
